Medicare Enrolled

Dr. Merrick Ross, M.D.

Surgical Oncology Physician · Houston, TX
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
1515 HOLCOMBE BLVD, Houston, TX 77030
7137926161
In practice since 2006 (19 years)
NPI: 1528154549 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Ross from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ross? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Ross

Dr. Merrick Ross is a surgical oncology physician in Houston, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Ross performed 459 Medicare services across 448 unique beneficiaries.

Between the years covered by Open Payments, Dr. Ross received a total of $227,725 from 10 pharmaceutical and/or device companies across 153 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in surgical oncology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Ross is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 14% volume in TX $227,725 industry payments

Medicare Practice Summary

Medicare Utilization ↗
459
Medicare services
Top 14% in TX for surgical oncology physician
448
Unique beneficiaries
$118
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~24 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
100 $47 $170
Intraoperative lymph node imaging
Imaging performed during surgery to visualize lymph nodes.
65 $113 $1,655
Deep underarm lymph node biopsy or removal
A procedure to remove or sample deep lymph nodes located in the underarm area for examination.
40 $284 $3,965
Injection of radioactive material for lymph node identification
A radioactive substance is injected to help locate lymph nodes during imaging procedures.
38 $13 $1,536
Punch biopsy of first skin growth
A small, circular piece of skin is removed from a skin growth using a circular blade. The sample is then sent to a laboratory for examination.
33 $35 $373
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
33 $106 $491
Surgical removal of skin cancer, 2.1-3.0 cm
This procedure involves the surgical excision of a cancerous skin growth located on the body, arms, or legs. The size of the removed tissue measures between 2.1 and 3.0 centimeters.
32 $115 $1,047
Deep neck lymph node biopsy or removal
A procedure to remove or sample deep lymph nodes located in the neck for examination.
31 $258 $3,495
Surgical removal of large skin cancer growth
Surgical excision of a malignant skin lesion located on the body, arms, or legs that measures more than 4.0 centimeters in diameter.
17 $143 $1,896
Complicated wound repair, each additional 5 cm or less
This code covers the additional work for a complex surgical repair of a wound on the scalp, arms, or legs when the repair extends beyond the initial measurement. It is billed for each incremental 5-centimeter segment added to the primary procedure.
16 $65 $578
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
16 $27 $123
Complicated wound repair, scalp/arms/legs, 2.6-7.5 cm
A complex surgical procedure to close a wound on the scalp, arms, or legs that measures between 2.6 and 7.5 centimeters in length.
13 $100 $1,516
Partial removal of breast 13 $566 $3,761
Surgical removal of large skin cancer growth
Surgical excision of a skin cancer lesion larger than 4.0 cm located on the scalp, neck, hands, feet, or genitals.
12 $119 $2,373
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$227,725
Total received (2018-2024)
Avg $32,532/year across 7 years
Top 2% in TX for surgical oncology physician
10
Companies
153
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$122,700 (53.9%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$98,237 (43.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$6,789 (3.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$40,219
2023
$32,712
2022
$39,753
2021
$18,240
2020
$21,219
2019
$37,468
2018
$38,115

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Merck Sharp & Dohme LLC
$112,442
Merck Sharp & Dohme Corporation
$83,641
Novartis Pharmaceuticals Corporation
$14,334
Amgen Inc.
$8,351
E.R. Squibb & Sons, L.L.C.
$5,050
Eisai Co., Ltd.
$3,750
GENZYME CORPORATION
$68
Janssen Biotech, Inc.
$35
EMD Serono, Inc.
$35
PFIZER INC.
$20
Top 3 companies account for 92.4% of total payments
Associated products mentioned in payments ›
IBRANCE · IMLYGIC · KEYTRUDA · Lenvima · MEKINIST · RYBREVANT · SARCLISA · TAFINLAR · TEPMETKO · VIJOICE
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (54%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 2% for surgical oncology physician in TX.

Equivalent to $49,613 per 100 Medicare services performed
Looking for a surgical oncology physician in Houston?
Compare surgical oncology physicians in the Houston area by procedure volume, costs, and industry payment transparency.
Browse surgical oncology physicians nearby

Geographic Context

Surgical oncology physicians within 10 mi
60
Per 100K population
1.3
County median income
$73,104
Nearest hospital
MEMORIAL HERMANN - TEXAS MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Ross is a clinical cardiology specialist, with above-average Medicare volume (top 14% in TX), with low-engagement industry engagement in the top 2% of TX peers, with 19 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Ross experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Ross performed 100 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Ross receive payments from pharmaceutical companies?
Yes. Dr. Ross received a total of $227,725 from 10 companies across 153 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ross's costs compare to other surgical oncology physicians in Houston?
Dr. Ross's average Medicare payment per service is $118. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ross) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →